Risk Assessment of Cardiovascular Disease in HIV Infected Individuals Receiving Antiretroviral Therapy - Shanghai Municipality, China, 2023

接受抗逆转录病毒治疗的HIV感染者心血管疾病风险评估——中国上海市,2023年

阅读:1

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Antiretroviral therapy (ART) is transforming human immunodeficiency virus (HIV) infection into a chronic condition, leading to an altered disease spectrum in patients. The risk of cardiovascular disease (CVD) in HIV-infected individuals are twice that of the general population. WHAT IS ADDED BY THIS REPORT? This study demonstrates elevated cardiovascular risk among the HIV population. The findings reveal that traditional CVD risk factors are prevalent among people living with HIV but remain inadequately addressed in clinical practice. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? These findings underscore both the necessity and urgency of implementing systematic CVD risk screening and intervention programs for HIV population. Furthermore, the study emphasizes the critical need to develop CVD screening tools specifically calibrated for the HIV population in China.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。